This HTML5 document contains 54 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
dctermshttp://purl.org/dc/terms/
yago-reshttp://yago-knowledge.org/resource/
dbohttp://dbpedia.org/ontology/
foafhttp://xmlns.com/foaf/0.1/
n10https://global.dbpedia.org/id/
n11http://www.ema.europa.eu/ema/index.jsp%3Fcurl=pages/regulation/general/
dbthttp://dbpedia.org/resource/Template:
rdfshttp://www.w3.org/2000/01/rdf-schema#
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
wikipedia-enhttp://en.wikipedia.org/wiki/
dbchttp://dbpedia.org/resource/Category:
dbphttp://dbpedia.org/property/
provhttp://www.w3.org/ns/prov#
xsdhhttp://www.w3.org/2001/XMLSchema#
wikidatahttp://www.wikidata.org/entity/
dbrhttp://dbpedia.org/resource/

Statements

Subject Item
dbr:List_of_Guidances_for_Statistics_in_Regulatory_Affairs
dbo:wikiPageWikiLink
dbr:Guidances_for_statistics_in_regulatory_affairs
Subject Item
dbr:Guidances_for_statistics_in_regulatory_affairs
rdfs:label
Guidances for statistics in regulatory affairs
rdfs:comment
Guidances for statistics in regulatory affairs are applicable to the pharmaceutical industry and medical devices industry. These Guidances represent the current thinking of regulatory agencies on a particular subject. It is to be noted that the term “Guidances” is used in the USA, whereas the term “Guidelines” is used in Europe. Regulatory affairs, also called government affairs, is a profession within regulated industries, such as pharmaceutical and medical devices, where professionals such as statisticians are expected to implement regulatory guidance into their work practices.
dcterms:subject
dbc:Biostatistics dbc:Medical_statistics dbc:Clinical_trials
dbo:wikiPageID
53033516
dbo:wikiPageRevisionID
994948048
dbo:wikiPageWikiLink
dbr:Institute_for_Quality_and_Efficiency_in_Health_Care dbc:Medical_statistics dbr:ISO_14155 dbr:Kefauver_Harris_Amendment dbr:Health_technology_assessment dbr:International_Council_on_Harmonisation_of_Technical_Requirements_for_Registration_of_Pharmaceuticals_for_Human_Use dbr:European_Network_for_Health_Technology_Assessment dbr:Good_Clinical_Practice_Directive dbr:Thalidomide dbr:Medical_devices dbr:Federal_Food,_Drug,_and_Cosmetic_Act dbr:Food_and_Drugs_Act dbr:International_Conference_on_Harmonisation_of_Technical_Requirements_for_Registration_of_Pharmaceuticals_for_Human_Use dbr:Medicine dbr:Epidemiological_method dbr:List_of_Guidances_for_Statistics_in_Regulatory_Affairs dbr:Epidemiology dbr:Medical_statistics dbr:National_Institute_for_Health_and_Care_Excellence dbr:Canadian_Agency_for_Drugs_and_Technologies_in_Health dbr:Medicines_and_Healthcare_products_Regulatory_Agency dbr:European_Medicines_Agency dbr:Good_Clinical_Practice dbr:Pharmaceutical_industry dbr:Pharmaceuticals_and_Medical_Devices_Agency dbr:Good_clinical_practice dbr:Food_and_Drug_Administration dbr:Clinical_trials dbc:Biostatistics dbr:Agency_for_Healthcare_Research_and_Quality dbr:Elixir_sulfanilamide dbr:Medicines_Act_1968 dbc:Clinical_trials
dbo:wikiPageExternalLink
n11:general_content_000602.jsp&mid=WC0b01ac05807d91a4
owl:sameAs
n10:2oX1q wikidata:Q30314123 yago-res:Guidances_for_statistics_in_regulatory_affairs
dbp:wikiPageUsesTemplate
dbt:Biology-footer dbt:Reflist dbt:TOC_right dbt:Orphan
dbo:abstract
Guidances for statistics in regulatory affairs are applicable to the pharmaceutical industry and medical devices industry. These Guidances represent the current thinking of regulatory agencies on a particular subject. It is to be noted that the term “Guidances” is used in the USA, whereas the term “Guidelines” is used in Europe. Regulatory affairs, also called government affairs, is a profession within regulated industries, such as pharmaceutical and medical devices, where professionals such as statisticians are expected to implement regulatory guidance into their work practices. Statisticians working in a regulated environment (e.g. the pharmaceutical and healthcare industry) are obliged to have a sound knowledge and understanding of the regulatory requirements that affect the design, conduct, analysis and reporting of their studies. Regulatory guidance for the pharmaceutical and medical devices industry can be found at the international level (e.g. ICH - International Council on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use), as well as at the regional/national level; for example: * EMA - European Medicines Agency in Europe, * MHRA - Medicines and Healthcare products Regulatory Agency in UK, * IQWiG - Institute for Quality and Efficiency in Health Care in Germany, * FDA - Food and Drug Administration in USA and * PMDA - Pharmaceuticals and Medical Devices Agency in Japan. Furthermore, statistical regulatory guidance is found under general topics (e.g. Good Clinical Practice - ICH E6(R2)) and specific ones explicitly related to statistics (e.g. Statistical Principles for Clinical Trials - ICH E9 ) or not explicitly (e.g. Special Populations: Geriatrics [ICH E7] or Clinical Trial Endpoints in Oncology [FDA]). This large volume and diversity of regulatory guidances (draft and/or final ) is subject to revisions. Therefore, users of the guidances are advised to consult the original website to check for the latest version. Users are also encouraged to update the Wikipedia content The Wikipedia List of Guidances for Statistics in Regulatory Affairs provides links to various guidances under different topics.
prov:wasDerivedFrom
wikipedia-en:Guidances_for_statistics_in_regulatory_affairs?oldid=994948048&ns=0
dbo:wikiPageLength
7363
foaf:isPrimaryTopicOf
wikipedia-en:Guidances_for_statistics_in_regulatory_affairs
Subject Item
wikipedia-en:Guidances_for_statistics_in_regulatory_affairs
foaf:primaryTopic
dbr:Guidances_for_statistics_in_regulatory_affairs